EP2355788B1 - Depilatory composition - Google Patents

Depilatory composition Download PDF

Info

Publication number
EP2355788B1
EP2355788B1 EP09768541.6A EP09768541A EP2355788B1 EP 2355788 B1 EP2355788 B1 EP 2355788B1 EP 09768541 A EP09768541 A EP 09768541A EP 2355788 B1 EP2355788 B1 EP 2355788B1
Authority
EP
European Patent Office
Prior art keywords
oil
weight
acid
thioglycolate
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP09768541.6A
Other languages
German (de)
French (fr)
Other versions
EP2355788A2 (en
Inventor
Asa Mansson
Candice Monge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt and Colman Overseas Ltd
Original Assignee
Reckitt and Colman Overseas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Overseas Ltd filed Critical Reckitt and Colman Overseas Ltd
Publication of EP2355788A2 publication Critical patent/EP2355788A2/en
Application granted granted Critical
Publication of EP2355788B1 publication Critical patent/EP2355788B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00Preparations for removing hair or for aiding hair removal
    • A61Q9/04Depilatories
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin

Definitions

  • the present invention relates to a depilatory cream composition.
  • the present invention relates to a depilatory cream which has improved odour properties.
  • Depilatory creams for removing unwanted hair are known. Such creams typically include a depilatory active that degrades hair keratin.
  • the active agent in depilatory creams is based on a sulphur-containing compound such as potassium thioglycolate.
  • a sulphur-containing compound such as potassium thioglycolate.
  • An unpleasant odour is commonly associated with this type of compound.
  • the depilatory active achieves its effect by weakening the hair. In doing so the depilatory active acts as reducing which results in the production of volatile sulphur-containing compounds. These sulphur-containing compounds also have an unpleasant odour.
  • the depilation cream is applied to a user's skin and left for a period of upto 10 mins while the active achieves its effect.
  • WO 2004/004645 describes the use of strontium salts to reduce malodours associated with hair removal compositions.
  • the depilatory composition may contain a skin-feel enhancing agent selected from at least one of silicone wax, talc and polyamide resin in the depilatory cream composition.
  • a skin-feel enhancing agent selected from at least one of silicone wax, talc and polyamide resin in the depilatory cream composition.
  • the silicone wax, talc and/or a polyamide resin impart(s) a soft and velvety after-feel to the depilatory cream composition without affecting the composition's hair removal properties.
  • Talc is particularly preferred over other minerals which have previously been used in cosmetics as it confers a powdery after-feel which is desirable. In addition, it does not alter the colour of the composition.
  • the talc may be present in an amount of 0.1 preferably 0.5 to 3 weight %. In one embodiment, the composition includes 1 to 2 weight % talc.
  • the depilatory cream composition may further include a humectant.
  • Suitable humectants include polyols, such as glycerine, propylene glycol and butylene glycol. Glycerine is preferred.
  • the humectant may be present in an amount of 0 to 10 weight %, preferably 0.5 to 5 weight %.
  • the composition may comprise a polyamide resin as an alternative or in addition to the mineral.
  • the polyamide resin may be present in an amount of 0.1 to 10 weight %, preferably 0.5 to 5 weight %, more preferably 1 to 3 weight %, for example 2 weight %.
  • the polyamide resin is preferably Nylon-12.
  • the composition may also comprise a silicone wax as an alternative or in addition to the mineral and/or polyamide resin.
  • Suitable silicone waxes include C 30 -C 45 alkyl methicone and a silicone wax formed from stearoxytrimethylsilane and stearyl alcohol.
  • the silicone wax is preferably C 30 -C 45 alkyl methicone.
  • the silicone wax may be present in an amount of 0.1 to 10 weight %, preferably 0.5 to 5 weight %, more preferably 1 to 3 weight %, for example 1 to 2 weight %.
  • the emollient is selected from at least one of mineral oil, silicone and emollient esters. Together with the silicone wax, mineral and/or polyamide resin (and optional humectant), the emollient plays an important role in providing the depilatory cream composition with its desired skin-feel characteristics.
  • the emollient may be present in an amount of 1 to 10 weight %, preferably 3 to 7 weight % of the composition.
  • Mineral oil may be present in an amount of 0 to 10 weight %, preferably 0.5 to 5 weight % of the composition.
  • Silicone oil may be present in an amount of 0 to 10 weight %, preferably 0.5 to 5 weight %, for example 1 to 4 weight % of the composition.
  • Emollient esters may be present in an amount of 0 to 10 weight %, preferably 0.5 to 5 weight % of the composition, for example 1 to 3 weight %.
  • the emollient in one embodiment, includes talc and an emollient that consists essentially of mineral oil.
  • the emollient is present in an amount of 3 to 6 weight %, preferably 5 weight %.
  • the talc is present in an amount of 0.3 to 1 weight %, preferably 0.5 weight %.
  • the composition preferably includes a humectant, such as glycerine.
  • the emollient may comprise or consist essentially of silicone oil(s).
  • a combination of silicone oils are present.
  • the silicone oil may include at least one of cyclopentasiloxane, dimethiconol and dimethicone.
  • the silicone oil comprises cyclopentasiloxane, dimethiconol and dimethicone.
  • the silicone oil may include 0.1 to 5 weight %, preferably 1 to 2 weight % dimethicone; and/or 1 to 5 weight %, for example, 1 to 3 weight % cyclopentasiloxane and dimethiconol.
  • the emollient it is possible for the emollient to consist essentially of an emollient ester.
  • the emollient ester is preferably used in combination with a mineral oil and/or a silicone oil.
  • the emollient comprises at least two of mineral oil, silicone oil and emollient esters.
  • the emollient may include mineral oil and silicone oil, or mineral oil and emollient esters, or silicone oil and emollient esters.
  • the emollient includes mineral oil, silicone oil and emollient esters.
  • silicone oil examples include cyclopentasiloxane, dimethiconol and dimethicone.
  • the total amount of silicone oil in the composition may be 0.1 to 10 weight %, for example, 2 to 5 weight %.
  • emollient ester Any suitable emollient ester may be employed. Suitable examples include isopropyl palmitate, isopropyl myristate, myristyl lactate, cetyl esters, isotridecyl isononanoate, C 12-15 alkyl benzoate, caprylic/capric triglyceride and pentaerythrityl tetraisostearate.
  • the emollient comprises mineral oil.
  • the mineral oil may be present in an amount of 3 to 6 weight %, preferably 5 weight %.
  • this combination of emollients is used together with at least one of talc and polyamide resin.
  • this combination of emollients is used together with at least one of talc and polyamide resin.
  • the composition is preferably substantially or, more preferably, is completely free from depilatory agents that destroy the thermodynamic equilibrium or the surface tension of the composition; examples of such agents include alkali metal sulphides.
  • Preferred depilatory compounds are thioglycolates, or their precursor thioglycolic acid. Most preferred is potassium thioglycolate, which may be produced by mixing thioglycolic acid with a neutralising source of potassium hydroxide.
  • the depilatory active may be present in an amount of 2 to 25 weight %, preferably 5 to 20 weight %, more preferably 10 to 15 weight %.
  • the composition includes potassium thioglycolate in an amount of 2 to 25 weight %, preferably 5 to 20 weight %, more preferably 10 to 15 weight %.
  • the depilatory cream composition of the present invention preferably includes water.
  • Water may be present in an amount of at least 40 weight %, preferably at least 50 weight %. Suitable amounts of water range from 40 to 70 weight %, preferably 50 to 65 weight %, more preferably 55 to 60 weight %.
  • the depilatory cream composition may optionally include one or more surfactant(s).
  • the surfactant may be anionic, cationic or non-ionic. It is preferably non-ionic.
  • suitable surfactants include cetearyl phosphate, cetearyl alcohol, cetearyl glucoside, cetostearyl alcohol and/or ceteareth 20. It is preferably present in an amount of from 0.5 to 15 wt% relative to the weight of the depilatory cream composition, more preferably from 1 to 10 wt%.
  • the depilatory cream composition may optionally include a source of alkalinity.
  • a source of alkalinity may include hydroxides, such as hydroxides of alkali and alkaline earth metals. Suitable hydroxides include sodium hydroxide, potassium hydroxide, calcium hydroxide and magnesium hydroxide. Preferably, calcium hydroxide is employed, optionally together with potassium hydroxide.
  • the source of alkalinity e.g. calcium hydroxide
  • the depilatory cream composition preferably has a pH of greater than 7, for example, 9 to 12.5.
  • the composition includes an accelerator that will accelerate the hair removal reaction.
  • accelerators include urea, thiourea, dimethyl, isosorbide (DMI), ethoxydiglycol (Transcutol) or methyl propyl diol (MP diol).
  • the accelerator is urea.
  • the composition according to the invention preferably comprises from 5% to 15% wt, more preferably from 6 to 10 wt% of an accelerator (e.g. urea).
  • the depilatory cream composition may comprise other optional ingredients, such as pigments and fillers, such as clays.
  • suitable clays include sodium magnesium silicate, magnesium trisilicate and titanium dioxide.
  • the inclusion of a clay, preferably sodium magnesium silicate, more preferably in an amount of from 0.1 to 10 wt% relative to the weight of the depilatory composition, most preferably from 0.1 to 1 wt%, is particularly advantageous, since this provides sodium and magnesium ions for the buffer system and improves the efficiency of depilation.
  • the depilatory cream composition desirably includes a chelating agent, such as sodium gluconate.
  • a chelating agent such as sodium gluconate.
  • the chelating agent may be present in an amount of less than 1 weight %, preferably 0.01 to 0.5 weight %, for example 0.05 to 0.1 weight %.
  • the depilatory cream composition may also include an additive that prevents phase separation.
  • Suitable additives include polymers or copolymers of acrylic acid, for example, an acrylate copolymer. Such additives may be present in an amount of up to 2 weight %, preferably less than 1 weight %, more preferably less than 0.5 weight %, for example 0.1 to 0.4 weight %.
  • additives such as aloe vera and Vitamin E may also be included in the composition.
  • additives are employed in amounts of less than 1 weight %, for example, 0.1 to 0.5 weight % of the composition.
  • the composition can be in the form of a base cream, an aerosol cream or a shower cream.
  • the composition is allowed a residence time on the skin.
  • the residence time is less than 10 minutes, more preferably not more than 6 minutes, even.
  • the residence time is 1 to 5 minutes, about 2 to 3 minutes being especially preferred.
  • composition of the present invention depilation after a residence time of only 3 minutes can be excellent, yet without significant skin irritation in subjects with normal skin.
  • composition may be removed from the skin by any means, for example using a sponge, spatula or scraper device.
  • compositions can be formulated using standard techniques known to the man skilled in the art.
  • composition of the present invention is that there is provided a composition which reduces the unpleasant malodour experienced by an individual when using currently available compositions.
  • the malodour score for the example embodiments described previously is given below.
  • compositions typically have a malodour score of greater than 4.
  • the formulation given below has a score of 4.
  • Component Wt% Deionised Water 58.095 Urea 8.00 Paraffinum Liquidum 5.00 Cetearyl alcohol 30/70 4.40 Potassium thioglycolate 12.90 Calcium hydroxide 3.56 Talc 2.00 Ceteareth-20 1.76 Glycerin 1.00 Potassium hydroxide 1.00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Description

  • The present invention relates to a depilatory cream composition. In particular, the present invention relates to a depilatory cream which has improved odour properties.
  • Depilatory creams for removing unwanted hair are known. Such creams typically include a depilatory active that degrades hair keratin.
  • Typically, the active agent in depilatory creams is based on a sulphur-containing compound such as potassium thioglycolate. An unpleasant odour is commonly associated with this type of compound. The depilatory active achieves its effect by weakening the hair. In doing so the depilatory active acts as reducing which results in the production of volatile sulphur-containing compounds. These sulphur-containing compounds also have an unpleasant odour.
  • Furthermore, In use the depilation cream is applied to a user's skin and left for a period of upto 10 mins while the active achieves its effect.
  • WO 2004/004645 describes the use of strontium salts to reduce malodours associated with hair removal compositions.
  • It would, therefore, be desirable to use a depilatory cream which avoids the unpleasant odours of creams currently available.
  • According to the present invention there is provided a use of one or more volatile, essential oils in accordance with Claim 1.
  • The depilatory composition may contain a skin-feel enhancing agent selected from at least one of silicone wax, talc and polyamide resin in the depilatory cream composition. In particular, the silicone wax, talc and/or a polyamide resin impart(s) a soft and velvety after-feel to the depilatory cream composition without affecting the composition's hair removal properties.
  • Talc is particularly preferred over other minerals which have previously been used in cosmetics as it confers a powdery after-feel which is desirable. In addition, it does not alter the colour of the composition. The talc may be present in an amount of 0.1 preferably 0.5 to 3 weight %. In one embodiment, the composition includes 1 to 2 weight % talc.
  • The depilatory cream composition may further include a humectant. Suitable humectants include polyols, such as glycerine, propylene glycol and butylene glycol. Glycerine is preferred. The humectant may be present in an amount of 0 to 10 weight %, preferably 0.5 to 5 weight %.
  • The composition may comprise a polyamide resin as an alternative or in addition to the mineral. The polyamide resin may be present in an amount of 0.1 to 10 weight %, preferably 0.5 to 5 weight %, more preferably 1 to 3 weight %, for example 2 weight %. The polyamide resin is preferably Nylon-12.
  • The composition may also comprise a silicone wax as an alternative or in addition to the mineral and/or polyamide resin. Suitable silicone waxes include C30-C45 alkyl methicone and a silicone wax formed from stearoxytrimethylsilane and stearyl alcohol. The silicone wax is preferably C30-C45 alkyl methicone.
  • The silicone wax may be present in an amount of 0.1 to 10 weight %, preferably 0.5 to 5 weight %, more preferably 1 to 3 weight %, for example 1 to 2 weight %.
  • The emollient is selected from at least one of mineral oil, silicone and emollient esters. Together with the silicone wax, mineral and/or polyamide resin (and optional humectant), the emollient plays an important role in providing the depilatory cream composition with its desired skin-feel characteristics.
  • The emollient may be present in an amount of 1 to 10 weight %, preferably 3 to 7 weight % of the composition.
  • Mineral oil may be present in an amount of 0 to 10 weight %, preferably 0.5 to 5 weight % of the composition.
  • Silicone oil may be present in an amount of 0 to 10 weight %, preferably 0.5 to 5 weight %, for example 1 to 4 weight % of the composition.
  • Emollient esters may be present in an amount of 0 to 10 weight %, preferably 0.5 to 5 weight % of the composition, for example 1 to 3 weight %.
  • It is possible for the emollient to consist essentially of mineral oil. For example, in one embodiment, the composition includes talc and an emollient that consists essentially of mineral oil. In this embodiment, the emollient is present in an amount of 3 to 6 weight %, preferably 5 weight %. The talc is present in an amount of 0.3 to 1 weight %, preferably 0.5 weight %. Where an emollient consisting essentially of mineral oil emollient is employed, the composition preferably includes a humectant, such as glycerine.
  • It is also possible for the emollient to comprise or consist essentially of silicone oil(s). Preferably, a combination of silicone oils are present. The silicone oil may include at least one of cyclopentasiloxane, dimethiconol and dimethicone. Preferably, the silicone oil comprises cyclopentasiloxane, dimethiconol and dimethicone. The silicone oil may include 0.1 to 5 weight %, preferably 1 to 2 weight % dimethicone; and/or 1 to 5 weight %, for example, 1 to 3 weight % cyclopentasiloxane and dimethiconol.
  • It is possible for the emollient to consist essentially of an emollient ester. However, the emollient ester is preferably used in combination with a mineral oil and/or a silicone oil.
  • In one embodiment, the emollient comprises at least two of mineral oil, silicone oil and emollient esters. For example, the emollient may include mineral oil and silicone oil, or mineral oil and emollient esters, or silicone oil and emollient esters. In one embodiment, the emollient includes mineral oil, silicone oil and emollient esters.
  • Any suitable silicone oil may be employed. Examples include cyclopentasiloxane, dimethiconol and dimethicone. The total amount of silicone oil in the composition may be 0.1 to 10 weight %, for example, 2 to 5 weight %.
  • Any suitable emollient ester may be employed. Suitable examples include isopropyl palmitate, isopropyl myristate, myristyl lactate, cetyl esters, isotridecyl isononanoate, C12-15 alkyl benzoate, caprylic/capric triglyceride and pentaerythrityl tetraisostearate.
  • In one embodiment, the emollient comprises mineral oil. The mineral oil may be present in an amount of 3 to 6 weight %, preferably 5 weight %. In a preferred embodiment, this combination of emollients is used together with at least one of talc and polyamide resin. embodiment, this combination of emollients is used together with at least one of talc and polyamide resin.
  • The composition is preferably substantially or, more preferably, is completely free from depilatory agents that destroy the thermodynamic equilibrium or the surface tension of the composition; examples of such agents include alkali metal sulphides.
  • Preferred depilatory compounds are thioglycolates, or their precursor thioglycolic acid. Most preferred is potassium thioglycolate, which may be produced by mixing thioglycolic acid with a neutralising source of potassium hydroxide.
  • The depilatory active may be present in an amount of 2 to 25 weight %, preferably 5 to 20 weight %, more preferably 10 to 15 weight %. In one embodiment, the composition includes potassium thioglycolate in an amount of 2 to 25 weight %, preferably 5 to 20 weight %, more preferably 10 to 15 weight %.
  • The depilatory cream composition of the present invention preferably includes water. Water may be present in an amount of at least 40 weight %, preferably at least 50 weight %. Suitable amounts of water range from 40 to 70 weight %, preferably 50 to 65 weight %, more preferably 55 to 60 weight %.
  • The depilatory cream composition may optionally include one or more surfactant(s). The surfactant may be anionic, cationic or non-ionic. It is preferably non-ionic. Examples of suitable surfactants include cetearyl phosphate, cetearyl alcohol, cetearyl glucoside, cetostearyl alcohol and/or ceteareth 20. It is preferably present in an amount of from 0.5 to 15 wt% relative to the weight of the depilatory cream composition, more preferably from 1 to 10 wt%.
  • The depilatory cream composition may optionally include a source of alkalinity. This may include hydroxides, such as hydroxides of alkali and alkaline earth metals. Suitable hydroxides include sodium hydroxide, potassium hydroxide, calcium hydroxide and magnesium hydroxide. Preferably, calcium hydroxide is employed, optionally together with potassium hydroxide. The source of alkalinity (e.g. calcium hydroxide) may be present in an amount of 0.1 to 10 weight %, preferably 1 to 6 weight %, for example 2 to 5 weight % of the depilatory cream composition.
  • The depilatory cream composition preferably has a pH of greater than 7, for example, 9 to 12.5.
  • Optionally, the composition includes an accelerator that will accelerate the hair removal reaction. Examples of such accelerators include urea, thiourea, dimethyl, isosorbide (DMI), ethoxydiglycol (Transcutol) or methyl propyl diol (MP diol). Preferably the accelerator is urea. The composition according to the invention preferably comprises from 5% to 15% wt, more preferably from 6 to 10 wt% of an accelerator (e.g. urea).
  • The depilatory cream composition may comprise other optional ingredients, such as pigments and fillers, such as clays. Examples of suitable clays include sodium magnesium silicate, magnesium trisilicate and titanium dioxide. The inclusion of a clay, preferably sodium magnesium silicate, more preferably in an amount of from 0.1 to 10 wt% relative to the weight of the depilatory composition, most preferably from 0.1 to 1 wt%, is particularly advantageous, since this provides sodium and magnesium ions for the buffer system and improves the efficiency of depilation.
  • The depilatory cream composition desirably includes a chelating agent, such as sodium gluconate. The chelating agent may be present in an amount of less than 1 weight %, preferably 0.01 to 0.5 weight %, for example 0.05 to 0.1 weight %.
  • The depilatory cream composition may also include an additive that prevents phase separation. Suitable additives include polymers or copolymers of acrylic acid, for example, an acrylate copolymer. Such additives may be present in an amount of up to 2 weight %, preferably less than 1 weight %, more preferably less than 0.5 weight %, for example 0.1 to 0.4 weight %.
  • Optionally, additives such as aloe vera and Vitamin E may also be included in the composition. Such additives are employed in amounts of less than 1 weight %, for example, 0.1 to 0.5 weight % of the composition.
  • The composition can be in the form of a base cream, an aerosol cream or a shower cream.
  • In the method of depilation of the present invention the composition is allowed a residence time on the skin. Preferably the residence time is less than 10 minutes, more preferably not more than 6 minutes, even. Very suitably the residence time is 1 to 5 minutes, about 2 to 3 minutes being especially preferred.
  • It is found that using the composition of the present invention depilation after a residence time of only 3 minutes can be excellent, yet without significant skin irritation in subjects with normal skin.
  • The composition may be removed from the skin by any means, for example using a sponge, spatula or scraper device.
  • The following Examples further illustrate the present invention.
    Figure imgb0001
    Figure imgb0002
    Figure imgb0003
  • The compositions can be formulated using standard techniques known to the man skilled in the art.
  • An advantage of the composition of the present invention is that there is provided a composition which reduces the unpleasant malodour experienced by an individual when using currently available compositions. The malodour score for the example embodiments described previously is given below.
    Example Malodour score
    1 3.17
    2 3.42
    3 3.83
    4 2.13
    5 3.6
    6 2.32
    7 3.12
    8 4
  • Known compositions typically have a malodour score of greater than 4. For example, the formulation given below has a score of 4.
    Component Wt%
    Deionised Water 58.095
    Urea 8.00
    Paraffinum Liquidum 5.00
    Cetearyl alcohol 30/70 4.40
    Potassium thioglycolate 12.90
    Calcium hydroxide 3.56
    Talc 2.00
    Ceteareth-20 1.76
    Glycerin 1.00
    Potassium hydroxide 1.00
    Magnesium trisilicate 0.50
    Titanium dioxide 0.3303
    Propylene glycol 0.2667
    Li Mg silicate 0.20
    Sodium gluconate 0.10
    Acrylates copolymer 33 0.10
    Hydrated silica 0.025
    Lotus flower milk 0.100
    Shea butter 0.100
    C145380:3 0.003
    Parfum/Fragrance Thelma 200 (no essential oils) 0.56
  • Further modifications and improvements can be incorporated without departing from the scope of the invention disclosed herein.

Claims (10)

  1. The use of one or more volatile, essential oils selected from the group consisting of orange oil, cedarwood oil, patchouli oil, pine oil, cabreuva oil, guaiacwood oil, lavandin oil, bergamot oil, petitgrain paraguay oil, lavender oil, mint oil, virginia cedarwood oil, Citrus Aurantium dulcis oil and Citrus grandis oil to reduce the unpleasant malodour experienced by an individual when using a depilatory cream comprising a depilatory active selected from the group consisting of potassium thioglycolate, dithioetythritol, thioglycerol, thioglycol, thioxanthine, thiosalicylcic acid, N-acetyl-L-cysteine, lipic acid, NaHSO3, Li2S, Na2S, K2S, MgS, CaS, SrS, BaS, (NH4)2S, sodium dihydrolipoate 6, 8-dithiooctanoate, sodium 6,8-dithiooctanoate, salts of hydrogen sulphide, thioglycolic acid, 2-mercaptopropionic acid, 3-mercaptropropionic acid, thiomalic acid, ammonium thioglycolate, glyceryl monothioglycolate, monoethanolamine thioglycolate, diammonium dithiodiglycolate, ammonium thiolactate, monoethanolamine thiolactate, thioglycolamide, homo-cysteine, cysteine, glutathione, dithiothreitol, dihydrolipoic acid, 1,3-dithiopropanol, thioglycolamide, glycerylmonothioglycolate, thioglycolhydrazine, keratinase, hydrazine sulphate, hydrazine disulphate triisocyanate, guanidine thioglycolate, calcium thioglycolate or cysteamine.
  2. The use as claimed in Claim 1 wherein the volatile essential oil is selected from the group consisting of Citrus Aurantium dulcis oil and Citrus grandis oil.
  3. The use as claimed in Claim 1 or 2, wherein the composition further comprises a skin-enhancing agent.
  4. The use as claimed in Claim 3 wherein the skin-enhancing agent is a talc.
  5. The use as claimed in any one of the preceding Claims, which further includes a humectant.
  6. The use as claimed in claim 5, wherein the humectant is glycerine.
  7. The use as claimed in any one of the preceding Claims, which comprises 2 to 20 weight% depilatory active.
  8. The use as claimed in claim 7, wherein the depilatory active is potassium thioglycolate.
  9. The use as claimed in any one of the preceding Claims, which further comprises 1 to 10 weight% emollient.
  10. The use as claimed in Claim 9 wherein the emollient is mineral oil.
EP09768541.6A 2008-12-05 2009-12-04 Depilatory composition Active EP2355788B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0822257.2A GB0822257D0 (en) 2008-12-05 2008-12-05 Depilatory composition
PCT/GB2009/002817 WO2010064017A2 (en) 2008-12-05 2009-12-04 Depilatory composition

Publications (2)

Publication Number Publication Date
EP2355788A2 EP2355788A2 (en) 2011-08-17
EP2355788B1 true EP2355788B1 (en) 2014-02-12

Family

ID=40289576

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09768541.6A Active EP2355788B1 (en) 2008-12-05 2009-12-04 Depilatory composition

Country Status (10)

Country Link
US (1) US9573001B2 (en)
EP (1) EP2355788B1 (en)
JP (1) JP2012510982A (en)
CN (2) CN105534743A (en)
AU (1) AU2009323875B2 (en)
BR (1) BRPI0923253A2 (en)
CA (1) CA2744988A1 (en)
GB (1) GB0822257D0 (en)
MX (1) MX2011005894A (en)
WO (1) WO2010064017A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020136290A1 (en) 2018-12-24 2020-07-02 Viokox, S.A. Thermochromic container for depilatory compositions
WO2020161372A1 (en) 2019-02-04 2020-08-13 Viokox, S.A. Depilatory product with thermochromic effect

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2379703T3 (en) 2010-03-26 2012-04-30 The Procter And Gamble Company Hair removal method and hair removal kit
BR112013025582A2 (en) * 2011-04-28 2016-08-16 Procter & Gamble hair removal method and kit
US9717657B2 (en) * 2012-10-24 2017-08-01 Amy Dukoff Composition and method of using medicament for endodontic irrigation, stem cell preparations and tissue regeneration
US8961180B2 (en) * 2012-10-24 2015-02-24 Amy Dukoff Composition and method of using medicament for endodontic irrigation, stem cell preparations and tissue regeneration
US10226403B2 (en) * 2012-10-24 2019-03-12 Amy Dukoff Composition and method for using medicament for endodontic irrigation, stem cell preparation and tissue regeneration
JP7511973B2 (en) * 2020-03-24 2024-07-08 株式会社マンダム Hair removal composition

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2487558A (en) * 1948-02-24 1949-11-08 Kamlet Jonas Cream depilatory and process for preparing same
JP2886201B2 (en) * 1989-09-29 1999-04-26 登 栗原 Hair remover containing Yuzu extract
JPH0693909B2 (en) * 1990-11-27 1994-11-24 松下電工株式会社 Deodorant for shaver
JPH0515870A (en) * 1991-07-17 1993-01-26 Mitsubishi Materials Corp Sewage treating deodorant for circulation-type
JPH05161697A (en) * 1991-12-18 1993-06-29 Matsushita Electric Works Ltd Deodorant
FR2689395A1 (en) * 1992-04-01 1993-10-08 Mauger Charles Composition for the permanent depilation of the human body and material for its application.
JPH09103473A (en) * 1995-10-11 1997-04-22 Sanei Kagaku Kk Deodorant composition
FR2761262B1 (en) * 1997-04-01 2000-01-07 Denise Jocelyne Benhamou EASY HAIR REMOVAL
JP3784962B2 (en) * 1998-05-14 2006-06-14 一丸ファルコス株式会社 Hair growth inhibitor
DE29817970U1 (en) * 1998-10-08 1999-01-14 Wella Ag, 64295 Darmstadt Permanent hair shaping agent with microencapsulated perfume oil
JP2000344636A (en) * 1999-06-07 2000-12-12 Kao Corp Deodorant composition
JP2001316234A (en) * 2000-05-08 2001-11-13 Picaso Cosmetic Laboratory Ltd Body hair growth inhibitor
JP4098479B2 (en) * 2001-02-14 2008-06-11 株式会社資生堂 Deodorant perfume composition for hair cosmetics
JP2001220332A (en) * 2001-03-30 2001-08-14 Sanei Kagaku Kk Composition for formulating hair treatment preparation and hair treatment preparation
US20030118535A1 (en) * 2001-09-07 2003-06-26 Adam Lustbader Depilatory compositions and kits containing the same
DE20204421U1 (en) * 2002-03-20 2002-06-27 Bellinghausen, Bettina, Dr.med., 66740 Saarlouis Body hair removal fabric
WO2004004645A2 (en) * 2002-07-10 2004-01-15 Armkell Llc. Composition for lessening malodors during hair treatment and hair removal and method of use
JP2004105244A (en) * 2002-09-13 2004-04-08 Kumiko Mori Controlled release deodorization coating agent
JP2005068304A (en) * 2003-08-26 2005-03-17 Sanyo Chem Ind Ltd Epoxy resin composition
JP4249200B2 (en) * 2005-03-24 2009-04-02 昭和電工株式会社 Pharmaceutical composition
ZA200700473B (en) * 2006-01-16 2009-08-26 Reliance Life Sciences Pvt Ltd Process for increased patchulol content in essential oil of pogostemon cablin
GB0704599D0 (en) * 2007-03-09 2007-04-18 Reckitt Benckiser Uk Ltd Depilatory composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020136290A1 (en) 2018-12-24 2020-07-02 Viokox, S.A. Thermochromic container for depilatory compositions
WO2020161372A1 (en) 2019-02-04 2020-08-13 Viokox, S.A. Depilatory product with thermochromic effect

Also Published As

Publication number Publication date
US9573001B2 (en) 2017-02-21
EP2355788A2 (en) 2011-08-17
MX2011005894A (en) 2011-06-30
CA2744988A1 (en) 2010-06-10
JP2012510982A (en) 2012-05-17
AU2009323875B2 (en) 2015-07-23
CN105534743A (en) 2016-05-04
WO2010064017A2 (en) 2010-06-10
GB0822257D0 (en) 2009-01-14
AU2009323875A1 (en) 2010-06-10
WO2010064017A3 (en) 2011-05-12
BRPI0923253A2 (en) 2016-01-26
CN102238937A (en) 2011-11-09
US20110302723A1 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
US8709098B2 (en) Depilatory composition
EP2355788B1 (en) Depilatory composition
ES2356746T3 (en) DEPILATORY COMPOSITION IN THE FORM OF EMULSION, PREPARATION AND USE PROCEDURE.
AU2006290444A1 (en) Improvements in or relating to cosmetic compositions
EP1001735B1 (en) Depilatory compositions, methods for their preparation and their use
US20150113741A1 (en) Hair removal compositions
US20140309308A1 (en) Depilatory compositions
US20220265536A1 (en) Depilatory Compositions Comprising Aminoalkylpropanol
ES2368171T3 (en) DEPILATORY COMPOSITIONS.
US8658222B2 (en) Topical composition
EP2844351B1 (en) Novel depilatory compositions
JPH06192058A (en) Hair remover composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110609

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130308

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/92 20060101ALI20130927BHEP

Ipc: A61K 8/46 20060101AFI20130927BHEP

Ipc: A61Q 9/04 20060101ALI20130927BHEP

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

INTG Intention to grant announced

Effective date: 20131017

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20131129

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 651818

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602009021816

Country of ref document: DE

Effective date: 20140327

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20140212

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 651818

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140212

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140512

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140612

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140612

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009021816

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20141113

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602009021816

Country of ref document: DE

Effective date: 20141113

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141204

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141204

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141231

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140513

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20091204

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20151204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20151204

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: IT

Effective date: 20170710

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140212

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20200917 AND 20200923

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602009021816

Country of ref document: DE

Owner name: RECKITT & COLMAN (OVERSEAS) HEALTH LTD., SLOUG, GB

Free format text: FORMER OWNER: RECKITT & COLMAN (OVERSEAS) LTD., SLOUGH, BERKSHIRE, GB

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230513

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230929

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231012

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20231201

Year of fee payment: 15

Ref country code: IT

Payment date: 20231110

Year of fee payment: 15

Ref country code: DE

Payment date: 20231010

Year of fee payment: 15